Translated automatically – community improvements welcome.
Aripiprazole
Aripiprazole is an atypical antipsychotic that primarily acts as a partial dopamine D2 agonist and additionally modulates serotonin receptors. It is used for the treatment of schizophrenia, bipolar disorders, and other mental illnesses. Due to its pharmacological profile, it has a moderate side effect profile, with movement disorders occurring less frequently than with classical antipsychotics. The substance affects various neurotransmitter systems, thereby contributing to mood stabilization and reduction of psychotic symptoms.
Mechanism of Action
- 5-HT1A agonist
- 5-HT2A antagonist
- Dopamin-D2 partial agonist
Names / Identifiers
IUPAC: Aripiprazole
Mechanism of Action
Aripiprazol wirkt als partieller Agonist an Dopamin D2-Rezeptoren und als Agonist an Serotonin 5-HT1A-Rezeptoren, was zu einer Modulation der dopaminergen und serotonergen Aktivität im Gehirn führt.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Allergy to aripiprazole
- Severe liver disease
Known Risks
- medium
- Mögliche Nebenwirkungen umfassen Gewichtszunahme, Sedierung und extrapyramidale Symptome.
Safer Use
- Regular medical monitoring
- Watch for signs of side effects
Harm reduction tips do not replace medical advice.
Known Interactions
- CYP2D6 inhibitors
- CYP3A4 inhibitors
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.